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We aimed to elucidate the effects of PGE2 and PGF2a on the in vitro maturation (IVM) of
bovine oocytes. First, cumulus-oocyte complexes werematured in themedia supplemented
with or without PGE2, PGF2a, or PGE2 plus PGF2a for the final 24,12, or 6 h of culture. Then,
the cumulus-oocyte complexes were matured in the absence or presence of a PG endo-
peroxide synthase 2 (PTGS2) enzyme inhibitor (NS398) supplementedwith PGE2, PGF2a, or
PGE2 plus PGF2a. Finally, the expression of genes associated with PGs activity in cumulus
cells (PTGS2, PG E-synthase-1 [PTGES1], and aldo-keto reductase 1 [AKR1B1]) or oocytes
(receptors for PGE2 [PTGER2] and PGF2a [PTGFR]) of different competencies was quanti-
fied. Supplementation of the IVM medium with PGs did not improve in vitro embryo
production or embryo quality (P > 0.05). During maturation, the relative abundance of
PTGS2 transcripts increased (P < 0.05) only in the less-competent group, whereas those of
PTGES1 increased in the less-competent and in the more-competent groups. Conversely,
AKR1B1 expression decreased only in the less-competent group (P < 0.05). Receptors for
the PGE2 and PGF2a genes were very low or undetectable in oocytes. In conclusion, PGE2
and PGF2a are not recommended for media supplementation during maturation because
they have no effect on embryo development. Although genes related to PGs activity are
differentially expressed in cumulus cells of cumulus-oocyte complexes of different
competence during maturation, the expression of PGE2 and PGF2a receptor genes was
either not detectable or was detected at low levels in oocytes.
 2020 Elsevier Inc. All rights reserved.1. Introduction then a heterogeneous population of oocytes with differentFor in vitro embryo production (IVP) and other assisted
reproduction techniques in domestic animals, oocytes are
removed prematurely from the follicular environment and92; fax: 055 61 3340
. Dode).
. All rights reserved.levels of competence is used. Such a difference in oocyte
competence leads to a lower rate of embryo production
compared with that obtained with in vivo matured oocytes
[1]. This suggests that to increase IVP efficiency, a
better understanding of the mechanisms involved in the
maturation process is necessary so that the oocytes can
be provided with adequate conditions for complete
maturation.
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mimic the in vivo environment inwhich oocyte maturation
occurs physiologically. Research in this area has focused on
the addition of substances that are normally present in
follicular fluid or are necessary for the final preparation of
the follicle for ovulation. Various substances have already
been tested in the medium during in vitro maturation
(IVM), such as growth factors [2–4], antioxidants [5,6], and
hormones [7,8]. However, the results have been inconsis-
tent regarding the compounds that should be added during
maturation to obtain better results in IVP.
In the follicle environment, the preovulatory peak of LH
stimulates maturation, which is completed just before
ovulation [9]. During this period, in which maturation oc-
curs and the follicle rupture approaches, the intrafollicular
concentration of PGE2 and PGF2a increases in several
species [10–13]. This suggests that these PGs may play a
role in ovulation and oocyte maturation processes.
Prostaglandins are products of the metabolism of
arachidonic acid, synthesized from the sequential actions of
the PG endoperoxide synthase 2 (PTGS2) enzyme and
specific terminal synthases, including PG E synthase
(PTGES1–S3) and PG F synthase (PTGFS). Although the role
of PTGES in the synthesis of PGE2 has been well charac-
terized [14–18], little is known about the specific enzyme
responsible for the production of PGF2a. Despite the lack of
information, the main PTGFS reported in the literature
belong to the aldo-keto reductase 1C (AKR1C) and 1B
(AKR1B1) family [19,20].
Previous studies have reported that the presence of PGE2
in theoocytemicroenvironment stimulatescumulus cell (CC)
expansion [21,22], cell cycle progression, and initial embry-
onic development [23], as well as promoting the regulation
of apoptosis [24]. In fact, the presence of PGE2 receptors on
the oocyte and the COC has also been demonstrated, indi-
cating the possible direct action of PGE2 in the oocyte
[22,23]. Although PGF2a is often related to the ovulatory
process in ruminants [25], few studies have been carried out
to identify the role of PGF2a during COC maturation. How-
ever, Barreta et al [26] demonstrated that PGF2a added
during IVM induces the resumption of meiosis in the same
way as PGE2, suggesting a possible role for this PG in IVM.
Based on these considerations, we hypothesized that
the inclusion of PGE2 and PGF2a in the IVM culture im-
proves oocyte maturation and embryo production. We
evaluated the addition of both PGs at various time points
during IVM and used a specific PTGS2 inhibitor, NS398, to
elucidate the effect of PGs in maturation. We also attemp-
ted to determine whether the competence of the oocyte
could affect the expression profile of genes encoding the
enzymes involved in PGs synthesis and activity.
2. Material and methods
Unless otherwise indicated, chemicals were purchased
from Sigma (St. Louis, MO).
2.1. Recovery and selection of cumulus-oocyte complexes
Ovaries fromcrossbred females (Bos indicusBos taurus)
were collected from local abattoirs immediately afterslaughter, and transported in saline solution (0.9% NaCl)
supplemented with antibiotics (100 mg/mL streptomycin
and 100 IU/mLG penicillin) at temperatures of 35C to 36C.
Cumulus-oocyte complexes were aspirated from follicles of
3 to 8 mm diameter using an 18-gauge needle attached to a
10 mL syringe. Only the COCs presenting homogenous
cytoplasm and at least 3 layers of CCs were used.
To obtain COCswith differing degrees of competence, we
used the follicle size model previously described [27–29].
Briefly, follicles were dissected from the ovarian cortex,
measured using a graduated ocular (eyepiece micrometer
OSM-4 Olympus, Tokyo, Japan), and morphologically clas-
sified. Follicles measuring 1 to 2.9 mm and 6 to 8 mm in
diameter were selected, and the oocytes were used to
represent less and themore competentoocytes, respectively.
The COCs were released from the follicles by rupturing the
follicle wall. Only those with at least 3 layers of CCs and a
homogeneous cytoplasmwere used for further analysis.
2.2. In vitro maturation
After selection, COCs were washed and transferred to
droplets of the maturation medium. In the experiments
with oocytes with differing degrees of competence, the
COCswere transferred to 50 mL (10 oocytes) or 100 mL (11
oocytes) droplets of IVMmedium and coveredwithmineral
oil. In the other experiments, groups of up to 50 COCs were
transferred to a 5-well culture dish (WTA, Cravinhos-SP,
Brazil) containing 500 mL of the IVM medium. The IVM
medium consisted of TCM-199 with Earl's salts supple-
mented with 0.4% fatty acid–free BSA, 0.075 mg/mL ami-
kacin,1 mMpyruvate,1 mMcysteamine, and 0.01 UI/mL FSH.
The culturewas performed for 24h at 39C and5%CO2 in air.
To evaluate cumulus expansion, each COC was
measured using the Motic Image Plus 2.0 program (Motic
China Group Co, Ltd, Xia-men, China) before and after
maturation. Cumulus cell expansion during IVM was
determined by the difference between the mean area of all
COCs from each treatment before and after IVM.
For gene expression analyses, oocytes and CCs were
collected after 0 and 24 h of maturation and stored in
RNAlater (Ambion, Life Technologies, Carlsbad, CA) at
80C until RNA extraction. To remove CCs, the COCs were
transferred to a drop of 50 mL saline in PBS, where they
were stripped by successive pipetting until complete
removal of the CCs. After being completely denuded, the
oocytes were washed 3 times in PBS without magnesium
and calcium and individually transferred (2 mL) to a 0.2 mL
tube. Then, twice the volume of RNAlater was added to the
tube. The 50 mL drop of PBS containing the CCs removed
from COCs was washed by centrifuging twice for 2 min at
700  g. The supernatant was removed and RNAlater was
added to the pellet.
2.3. Embryo production
After maturation, groups of up to 50 COCs were
transferred to 200 mL drops of the fertilization medium,
which consisted of Tyrode's albumin lactate pyruvate
supplemented with penicillamine (2 mM), hypotaurine
(1 mM), epinephrine (250 mM), and heparin, 10 mg/mL
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for all treatments and replicates; this bull has been used
for several years as a reference bull for IVP in our labo-
ratory. Motile spermatozoa were obtained using the Per-
coll (GE Healthcare, Piscataway, NJ) gradient method in
microtubes [31] and were added to the fertilization drop at
a final concentration of 1  106 spermatozoa/mL. Sper-
matozoa and oocytes were coincubated for 18 h at 39C
with 5% CO2 in air. The day of in vitro insemination was
considered day 0. Eighteen hours after insemination, the
presumptive zygotes were washed and transferred to
200 mL drops of synthetic oviduct fluid medium with
amino acids, citrate, and inositol [32] supplemented with
0.4% BSA-FAF and 0.5 mg/mL of ITS (insulin 10 mg/L,
transferrin 5.5 mg/L, selenium 5 mg/L) and incubated at
39C in an atmosphere of 5% CO2 in air. Embryos were
evaluated on day 2 for cleavage and on days 6 and 7 for
blastocyst rates.
2.4. Total cell count and apoptosis rate
To determine the total number of cells and percentage
of apoptotic cells, D7 expanded blastocysts were submitted
to TUNEL analysis and H33342 treatment using the Click-iT
TUNEL Alexa Fluor Thermo Fisher Kit (Waltham, MA).
Expanded blastocysts were washed in PBS supplemented
with polyvinyl pyrrolidone (PVP; 1 mg/mL) and then fixed
in 3.7% paraformaldehyde for 15 min. After washing in
1 mg/mL PVP, the blastocysts were incubated in 0.5%
Triton-X for 20 min. Finally, the embryos were exposed to
the TUNEL and Alexa Fluor 488 enzymatic mix for 1 h at
37C and later to H33342 for 10 min. Finally, the embryos
were washed with PBS-PVP, mounted on glass slides, and
observed under a fluorescence microscope, using 495/
519 nm excitation wavelength filters for Alexa Fluor 488
and 350/461 nm excitation for H33342. For each blastocyst,
the total number of individual cells (blue nuclei, H33342)
and the total number of apoptotic cells (green nuclei,
TUNEL) were determined.
2.5. Real-time quantitative PCR
To analyze gene expression, the relative abundance of
transcripts for 5 genes associated with PGs activity wasTable 1
Information of specific primers used for amplification of gene fragment analysis
Gene Primer sequence Amplicon
size (bp)
Pr
GAPDH F: GGC GTG AAC CAC GAG AAG TATAA
R: CCC TCC ACG ATG CCA AAG T
118 30
PTGS2 F: GAG GAA CTT ACA GGA GAG AAG
R: CGG GAG AGC ATA TAG GAT TAC
193 25
PTGES1 F: TGG TCA TCA AAA TGT ACG TGG T
R: AGT AGA CAA AGC CCA GGA ACA G
201 20
AKR1B1 F: GTC TCC AAC TTC AAC CAT CTC
R: CTA TAG GCA GTC ACC ACA ATG
158 30
PTGER2 F: GCC ACT CTG CTG CTG TTG C
R: CCA TGG ATA CCC TTT CCG CT
151 20
PTGFR F: CAT CCA GCT TCT GGG TAT AAT G
R: GCGTCTGGTACACACATATAG
220 30
Abbreviations: F, primer forward; R, primer reverse; bp, base pairs.analyzed. PTGS2, PTGES1, and AKR1B1 were quantified in
CCs using RT-qPCR, whereas the receptors for PGE2
(PTGER2) and PGF2a (PTGFR) were quantified in oocytes.
The primer sequences, amplicon size, primer efficiency, and
primer concentration are listed in Table 1.
Total RNA was isolated from 4 pools of CCs obtained
from 17 COCs and 3 pools of 6 or 10 oocytes for each
treatment using the RNeasy Plus Micro Kit (Qiagen, Hilden,
Germany) according to the manufacturer's instructions.
Total RNA was used for cDNA synthesis, which was per-
formed using the Super Script III First-Strand cDNA Syn-
thesis kit (Invitrogen Carlsbad, CA), following the
manufacturer's recommendations in a final volume of
30 mL. Complementary deoxyribonucleic acid was synthe-
sized in a thermocycler at 65C for 5 min and 50C for
50 min, followed by inactivation of the enzyme at 85C for
5 min. Quantitative polymerase chain reaction was per-
formed using the Fast SYBR Green Master Mix kit (Applied
Biosystems, Foster City, CA). Each biological sample was
analyzed in triplicate, and the specificity of each PCR
product was determined by melting curve analysis and
determination of the amplicon size in agarose gel. Re-
actions were carried out in a final volume of 25 mL using a
cDNA template corresponding to 0.88 CCs or 0.66 oocytes
per reaction, according to each experiment. The conditions
of the qPCR were 95C for 5 min, followed by 50 cycles of
denaturation at 95C for 10 s, and annealing and extension
at 60C for 30 s.
To determine which housekeeping gene to use for data
normalization, 3 constitutive genes, glyceraldehyde-3-
phosphate dehydrogenase (GAPDH), b-actin, and pepti-
dylprolyl isomerase A, were analyzed using the GeNorm
program [33]. The analysis revealed GAPDH to be the most
stable gene for use in subsequent experiments with CCs
and PPIA for use in experiment with oocytes. The relative
expression of each gene was calculated using the DDCt
method with efficiency correction by the Pfaffl method
[34].
The expressions of genes not detected in oocytes were
assessed in different tissues (corpus luteum [CL]: 35 ng/
reaction; endometrium [End]: 35 ng/reaction; placenta
[Plac]: 50 ng/reaction; CCs [CC1: 0.8 CC/reaction and CC2:
1.6 CC/reaction]) and in different concentrations of cDNA
from oocytes (0.6 oocyte/reaction: 1.2 oocytes/reaction andby real-time PCR.
imer concentration (nM) Primers
efficiency
GenBank n/reference
0 94.54 NM_001034034.2
0 105.3 NM_174445.2
0 103.62 NM174443
0 109.23 NM_001012519.1
0 92.59 Nuttinck et al, 2011 [23]
0 87.43 NM_181025.3
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to confirm their presence and identity based on the ex-
pected size, corroborating the Tm and CT data.Table 2
Embryo development of bovine oocytes submitted to in vitro maturation
for 24 h in the absence (CTL) or in the presence of PGE2, PGF2a, or PGE2
associated to PGF2a.
Treatments No
total
D2 D6 D7
Cleavage N
(%)
Blastocysts
N (%)
Blastocysts
N (%)
CTL 97 79 (81.4)a 7 (7.2) 22 (22.6)
PGE2 81 51 (62.9)b 6 (7.4) 23 (28.3)
PGF2a 68 52 (76.4)ab 7 (10.2) 21 (30.8)
PGE2 þ
PGF2a
104 77 (74.0)ab 11 (10.5) 30 (28.8)
Abbreviations: CTL, control; D2, day 2 of in vitro embryo development;
D6, day 6 of in vitro embryo development; D7, day 7 of in vitro embryo
development.
a,bDifferent letters in the same column indicate significant differences (P<
0.05). Data analyzed by the chi-square test (P > 0.05).2.6. Experimental design
2.6.1. Experiment 1: effects of PGE2 and PGF2a during IVM of
bovine oocytes on embryo production
This experiment aimed to evaluate whether the addi-
tion of PGs during IVM of bovine oocytes would improve
embryo production. Initially, the COCs obtained by follic-
ular aspiration (3–8 mm diameter) were selected and
distributed into 4 groups: (1) CTL, control; (2) PGE2, the
maturationmediumwas supplementedwith 1 mMof PGE2;
(3) PGF2a, thematurationmediumwas supplementedwith
1 mM of PGF2a; and (4) PGE2 þ PGF2a, the maturation
mediumwas supplemented with 1 mMof PGE2 and 1 mMof
PGF2a. The cleavage rate on D2 and the blastocyst rates on
D6 and D7 were evaluated.
Then, we aimed to determine whether the addition of
PGs at different time points during IVM would affect sub-
sequent embryo production. Owing to the number of
treatments, it was not possible to supplement the media
with PGE2 and PGF2a simultaneously; therefore, 2 separate
experiments were carried out. For PGE2, COCs obtained by
follicular aspiration (3–8 mm in diameter) were selected
and distributed into 4 treatment groups: (1) CTL; (2) PGE2
during the 24 h of IVM; (3) PGE2 during the last 12 h of
IVM; and (4) PGE2 during the last 6 h of IVM. In this
sequence, the PGF2a effect was evaluated in a similar
manner as PGE2, using the same treatments; the difference
was that instead of PGE2, the PGF2a was added during the
24 h, the last 12 h, and the last 6 h of IVM. Cleavage on D2
and blastocyst rate on D6 and D7 were evaluated. Con-
centrations of PGE2 and PGF2a used in all the experiments
were based on those reported by Barreta et al [26].
2.6.2. Experiment 2: effects of PTGS2 inhibition during
maturation on cumulus expansion and embryo production
To ensure that the presence of PGs does not affect oocyte
IVM, we selected a PTGS2 inhibitor, which would prevent
the synthesis of both PGE2 and PGF2a. The COCs were
matured in the presence of a specific inhibitor of PTGS2
(NS398), and the medium was supplemented with either
PGE2 or PGF2a. The COCs obtained by follicular aspiration
(3–8 mm in diameter) were selected and distributed into 5
groups: (1) CTL; (2) NS398, the maturation medium was
supplemented with 10 mMof NS398; (3) NS398þ PGE2, the
maturation medium was supplemented with 10 mM of
NS398 and 1 mM of PGE2; (4) NS398 þ PGF2a, the matu-
ration medium was supplemented with 10 mM of NS398
and 1 mM of PGF2a, and (5) NS398 þ PGE2þ PGF2a, the
maturation medium was supplemented with 10 mM of
NS398, 1 mM of PGE2, and 1 mM of PGF2a. Expansion of the
CCs during maturation and the cleavage and blastocyst
rates were evaluated for each group. The total number of
cells and percentage of cells with DNA fragmentation was
determined by the TUNEL test in expanded D7 blastocysts.
The concentrations of NS398 used were according to Marei
et al [17].2.6.3. Experiment 3: expression of genes involved in the activity
of PGE2 and PGF2a during maturation in CCs and oocytes with
different levels of competence
In this experiment, we aimed to evaluate whether the
expression of genes related to PGs activity varies during
IVM. Considering that the in vivo expression of PTGS2,
which is essential for PGs synthesis, depends on follicle
size, we aimed to determine the association between gene
expression and the oocyte competence. The expression of
PTGS2 (PGE2 and PGF2a synthesis), PTGES1 (PGE2 specific
synthase), and AKR1B1 (PGF2a specific synthase) were
evaluated in CCs, and that of PTGER2 (PGE2 specific re-
ceptor) and PTGFR (PGF2a specific receptor) were evalu-
ated in oocytes from COCs of different categories. The COCs
used were obtained from follicles of 6 to 8 mm diameter
and from follicles of 1 to 2.9 mm in diameter, which were
previously described [27–29] as more competent (COM)
and less competent (INC), respectively.
3. Statistical analyses
Data on embryo development were analyzed by the chi-
square test (P < 0.05), total cell number by ANOVA, and
DNA fragmentation (TUNEL) by the Kruskal–Wallis test.
Cumulus cell expansion and gene expression were
compared between treatments by ANOVA and Tukey's test
if the data were normally distributed, whereas data not
normally distributed were evaluated using the Kruskal–
Wallis test. Differences were considered statistically sig-
nificant at the 95% confidence level (P < 0.05). All analyses
were performed using Prophet Statistics software, version
5.0 (BBN Systems and Technologies, Cambridge, MA; 1996).
4. Results
4.1. Experiment 1: effect of PGE2 and PGF2a during IVM of
bovine oocytes on embryo production
When COCs were cultured in the maturation media
supplemented with PGE2, PGF2a, or PGE2 and PGF2a, no
differences (P > 0.05) in the cleavage rate were observed,
except for the PGE2 group, which presented a lower (P <
0.05) rate than the CTL group. However, the blastocyst rates
Table 3
Embryo development of bovine oocytes submitted to in vitro maturation
for 24, 12, or the last 6 hours in the absence (CTL) or in the presence of the
PGE2.
Treatments N
total
D2 D6 D7
Cleavage
N (%)
Blastocysts
N (%)
Blastocysts
N (%)
CTL 231 202 (87.4)ab 25 (10.8)ab 73 (31.6)
PGE2 24 h 211 187 (88.6)a 24 (11.4)a 62 (29.4)
PGE2 12 h 223 183 (86.5)b 19 (8.5)ab 58 (26.0)
PGE2 6 h 214 189 (88.3)ab 13 (6.1)b 59 (27.6)
Abbreviations: CTL, control; D2, day 2 of in vitro embryo development;
D6, day 6 of in vitro embryo development; D7, day 7 of in vitro embryo
development.
a,bDifferent letters in the same column indicate significant differences (P<
0.05). Data analyzed by the chi-square test (P > 0.05).
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groups (Table 2). Similarly, the addition of PGE2 or PGF2a at
different time points during IVM did not alter embryo
development (Tables 3 and 4).Fig. 1. Expansion area of the cumulus-oocyte complexes matured for 24 h in
the absence (CTL) or presence of NS398, supplemented with PGE2, PGF2a or
PGE2 and PGF2a. The area was obtained from the difference between the
mean area of all COCs from each treatment before and after in vitro matu-
ration. CTL, control; COCs, cumulus-oocyte complexes.4.2. Experiment 2: effects of PTGS2 inhibition during
maturation on cumulus expansion and embryo production
and quality
To ensure that PGs did not affect maturation, COCs were
matured in the absence and presence of a PG synthesis
inhibitor, with or without supplementation with PGE2,
PGF2a, or PGE2þ PGF2a. The results showed that the
presence of PGE2 or PGF2a did not affect (P > 0.05) CC
expansion (Fig. 1).
Embryonic development data are presented in Table 5.
The cleavage rate was similar (P > 0.05) for all groups,
regardless of the treatment used. On D6, oocytes treated
with PGF2a þ NS398 presented a lower rate of blastocyst
formation thanoocytes fromNS398orCTLgroups (P<0.05).
On D7, the CTL group presented a higher blastocyst rate (P<
0.05) compared with other groups. Thus, PGs affected em-
bryonic development, and only the group in which NS398
alonewas added presented blastocyst production similar to
that in the CTL group. However, no difference was observed
between groups regarding the total number of cells and the
percentage of apoptotic cells (Table 6).Table 4
Embryo development of bovine oocytes submitted to in vitro maturation
for 24, 12, or the last 6 hours in the absence (CTL) or in the presence of the
PGF2a.
Treatments N
total
D2 D6 D7
Cleavage
N (%)
Blastocysts
N (%)
Blastocysts
N (%)
CTL 220 184 (83.6) 9 (4.1) 57 (25.9)
PGF2a 24 h 227 198 (87.2) 11 (4.8) 59 (26.0)
PGF2a 12 h 243 204 (84.0) 11 (4.5) 50 (20.6)
PGF2a 6 h 232 180 (77.6) 15 (6.5) 47 (20.3)
Abbreviations: CTL, control; D2, day 2 of in vitro embryo development;
D6, day 6 of in vitro embryo development; D7, day 7 of in vitro embryo
development.
Data analyzed by the chi-square test (P > 0.05).4.3. Experiment 3: expression of genes involved in the activity
of PGE2 and PGF2a during maturation in CCs and oocytes with
different competence
To determine the expression of genes involved in the
activity of PGE2 and PGF2a, and to evaluate whether the
expression profile varies during maturation according to
the competence of the COCs, 3 genes (PTGS2, PTGES1, and
AKR1B1) were quantified in CCs and 2 genes (PTGER2 and
PTGFS) in oocytes. The results showed that the expression
of PTGS2 increased (P < 0.05) in the INC group during
maturation (Fig. 2A) and that of PTGES1 increased in the
INC and COM groups (Fig. 2B). Regarding the AKR1B1 gene,
the expression decreased in the INC group (P< 0.05) during
maturation (Fig. 2C).
When the expression of genes in CCs was compared
among groups of COCs at the same time of maturation, no
differences were found at 0 and 24 h of IVM, except for the
PTGS2 gene, which was expressed at lower levels in the
COM group (P< 0.05) compared with the INC group at 24 h
(Fig. 2A).
Expression of the PTGER2 and PTGFR genes was quan-
tified in immature andmature oocytes from the 2 groups of
COCs. The results revealed no expression of those genes in
any of the oocytes categories. To confirm that the genes
were not expressed in the oocytes, their expression was
also quantified in different bovine tissues, collected at ab-
attoirs, which were used as positive CTLs (CCs, CL, End, and
bovine Plac). As shown in Table 7 and Figure 3, CT values
associated with PGFR expression could not be determined,
even when template cDNA corresponding to 2.4 oocytes/
reaction was used. By contrast, the CT values for the
remaining tissues were between 27 and 32. Similarly,
expression of the PTGER2 gene was very low or
Table 5
Embryo development of bovine oocytes submitted to maturation for 24 h
in the absence (CTL) or in the presence of the inhibitor of the enzyme PG
endoperoxide synthase 2 (NS398) supplemented with PGE2, PGF2a, or
PGE2 and PGF2a.
Treatments N
total
D2 D6 D7
Cleavage
N (%)
Blastocysts
N (%)
Blastocysts
N (%)
CTL 254 207 (81.4) 20 (7.9)a 88 (34.6)a
NS398 241 186 (77.1) 22 (9.1)a 72 (29.8)ac
NS398 þ PGE2 236 186 (78.8) 16 (6.8) ab 60 (25.4)bc
NS398 þ PGF2a 215 163 (75.8) 8 (3.7)b 44 (20.4)b
NS398 þ PGE2
þ
PGF2a
231 186 (80.5) 18 (7.7)ab 61 (26.4)bc
Abbreviations: CTL, control; D2, day 2 of in vitro embryo development;
D6, day 6 of in vitro embryo development; D7, day 7 of in vitro embryo
development.
a,b,cDifferent letters in the same column indicate significant differences
(P < 0.05). Data were analyzed by the chi-square test (P > 0.05).
S.A.D. Rodrigues et al. / Domestic Animal Endocrinology 72 (2020) 1064476undetectable in all oocyte samples, whereas CT values
varied from 29 to 34 in other tissues (Table 7). The PCR
product was placed on the gel to confirm its presence and
was identified based on the expected size, corroborating
the Tm and CT data. This gene was expressed in all tissues
tested, but was not detected with any concentration of
oocytes (Fig. 3).Fig. 2. Levels of transcripts of the (A) PG endoperoxide synthase 2 (PTGS2),
(B) PG E synthase 1 (PTGES1), and (C) aldo-keto reductase 1B (AKR1B1)
genes, quantified by RT-qPCR in bovine cumulus cells of different compe-5. Discussion
During thematuration of the COC and the preparation of
follicles for ovulation, concentrations of PGE2 and PGF2a
increase in the follicular fluid of several species
[11,12,35,36], suggesting that those substances may play an
important role in the in vivo maturation process. Therefore,
in anattempt toelucidate the effect of PGsE2andF2aduring
the IVM of bovine COCs, we evaluated the ability of oocytes
matured in vitro in the presence or absence of both PGs, and
in the presence of an inhibitor of PG synthesis, to attain
normal embryodevelopment. In addition,wequantified the
expression of genes associatedwith the activity of these PGs
in CCs or oocytes before and after maturation to better un-
derstand the effects or PGs during IVP.Table 6
Total number of cells, and number and percentage of apoptotic cells in
expanded blastocysts, at day 7 of development, originating from cumulus-
oocyte complexes in the absence (CTL) or in the presence of the inhibitor
(NS398) of the enzyme PTGS2 supplemented with PGE2, PGF2a, or PGE2
and PGF2a.
Treatments N total BX N cells SD N apoptotic
Cells SD (%)
CTL 33 177.8  39.3 7.1  2.8 (4.0)
NS398 30 188.9  46.5 8.8  4.5 (4.6)
NS398 þ PGE2 33 185.2  30.6 7.9  3.3 (4.3)
NS398 þ PGF2a 29 185.0  42.2 7.6  4.1 (4.1)
NS398 þ PGE2þ
PGF2a
31 183.7  39.6 8.8  3.5 (4.8)
Abbreviation: CTL, control.
Data were analyzed by ANOVA (number of cells) and the Kruskal–Wallis
test (number and percentage of apoptotic cells).
tencies, follicles derived from 1.0 to 2.9 mm (incompetent group; INC) and
6.0–8.0 mm (competent group; COM), before (0 h) and after (24 h) in vitro
maturation. Data (mean  SD) were normalized by the GAPDH gene.The first experiment aimed to confirmwhether PGs can
be used as additives to improve embryo development of
bovine oocytes. First, the maturation medium was supple-
mented with PGE2, PGF2a, or PGE2 and PGF2a. The results
showed that supplementation of the IVMmediumwith PGs
do not promote additional effects in the in vitro production
of embryos. Similar results were reported by Marei et al
(2014) and Nuttinck et al (2017) after the addition of
different concentrations of PGE2 to the IVM medium.
However, PGF2a was not added to the IVM medium in
either of those studies.
Considering that under physiological conditions, PGE2
and PGF2a secretion is highest at the end of the maturation
Table 7
Threshold cycle and melting temperature values for cDNA amplification of glyceraldehyde-3-phosphate dehydrogenase, PGE2-specific receptor and PGF2a-
specific receptor genes, in duplicate, run using samples from corpus luteum, endometrium, cotyledon, oocyte (Ov1: 0.6 oocyte/reaction, Ov2: 1.2 oocytes/
reaction, and Ov3: 2.4 oocytes/reaction), and cumulus cells (CC1: 0.8 CC/reaction and CC2: 1.6 CC/reaction).
Sample name Biological replicate GAPDH PTGER2 PTGFR
Ct TM Ct TM Ct TM
Negative control 46.19 72.25 40.99 73.61 46.83 72.42
Corpus luteum 1 21.53 79.35 30.77 82.89 27.18 74.45
Corpus luteum 2 21.53 79.52 30.74 82.89 27.16 74.28
Endometrium 1 20.23 79.68 29.24 83.06 31.47 74.28
Endometrium 2 20.21 79.68 29.09 83.06 30.80 74.45
Cotyledon 1 18.64 79.68 33.54 81.71 29.80 74.28
Cotyledon 2 18.69 79.68 34.80 81.54 29.46 74.45
CC 1 1 19.37 79.85 33.97 81.88 32.33 74.45
CC 1 2 19.44 79.85 34.33 82.22 31.88 74.62
CC 2 1 18.08 79.68 32.55 82.05 30.89 74.62
CC 2 2 18.12 79.68 32.86 82.05 30.77 74.62
Ov. 1 1 27.88 79.52 39.97 72.25 Undetermined 67.53
Ov. 1 2 28.08 79.52 Undetermined 72.09 Undetermined 73.61
Ov. 2 1 26.75 79.52 36.87 78.00 Undetermined 68.37
Ov. 2 2 26.69 79.52 40.46 73.61 Undetermined 73.10
Ov. 3 1 21.80 79.85 37.06 72.09 Undetermined 66.34
Ov. 3 2 21.80 79.85 42.41 71.58 Undetermined 67.70
Abbreviations: CTL, control; Ct, threshold cycle; TM, melting temperature.
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observed on the presence of PGs throughout the 24 h could
be due to an excessive exposure to PGs during maturation.
Then, we also evaluated the addition of these PGs at
different times during IVM (final 24, 12, or 6 h of culture).
However, no differences in cleavage and blastocyst rates
were also detected at any supplementation times. These
data suggested that neither PGE2 nor PGF2a are suitable
additives for enhancing the embryonic development of
bovine oocytes.
Taking into account our results, in which PGs have no
effect during maturation and the information that PGs are
synthesized during maturation both in vivo and in vitro
[18,23,36,38–41], one could think that the PGs synthesized
in culture is sufficient to cause their effects. If this is true, it
is not necessary to supplement the media with PGs. To test
that, we used a specific inhibitor of PTGS2 during IVM. First,
the results showed that neither the addition of an inhibitor
nor supplementation of NS398 with PGs altered the levels
of CC expansion. Similar results were reported by Marei
et al (2014) with the same inhibitor (NS398), or with siRNA-Fig. 3. Validation of PGE2-specific receptor (PTGER2) and PGF2a-specific receptor (
reaction, Ov2: 1.2 oocytes/reaction and Ov3: 2.4 oocytes/reaction; cumulus cells–C
action; endometrium–End: 35 ng/reaction; and placenta–Plac: 50 ng/reaction). GAP
gels showing specific amplicons for GAPDH (118 bp), PTGER2 (151 bp), and PTGFRPTGS2 (PTGS2-specific interference RNA), or NS398 and
siRNA-PTGS2. However, others have reported a beneficial
effect of PGE2 on expansion after addition to the IVM me-
dium [21,22]; however, the effect was only significant when
COCs were cultured in the presence of serum or in the
absence of hormones [22,42]. Serum was not used in the
present study, and the levels of expansion in the treated
groups were similar to those in the CTL group; therefore, it
is possible that the presence of FSH induced the expansion,
and that PGE2 and PGF2a had no effect under the condi-
tions used in this study.
Similar to CC expansion, supplementation of the matu-
rationmediumwith the inhibitor and PGs did not affect the
cleavage rate. However, the addition of PGE2 and PGF2a to
the NS398-treated medium affected embryo development,
resulting in lower rates of D7 blastocysts in all PG-treated
groups compared with the CTL group. Notably, no
changes in embryo quality were observed. Results indicate
that PGs synthesis is not essential for IVM and that the
addition of PGE2 and PGF2a to the medium treated with
NS398 may negatively affect embryo production. ThesePTGFR) gene expression in different bovine tissues (oocyte–Ov1: 0.6 oocyte/
C1: 0.8 CC/reaction and CC2: 1.6 CC/reaction; corpus luteum–CL: 35 ng/re-
DH gene was used as the endogenous control. Electrophoresis of 2% agarose
(220 bp); the DNA ladder used is 1 kb plus (Invitrogen).
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ature, as recent studies using bovine COCs have reported
that the addition of PGE2 during IVM and IVF treated with
NS398 restored the negative effects on the blastocyst rate
in D6, the number of blastomeres in D6 and D7 embryos
[23], and on the average length of D14 embryos [24].
Conversely, it is well established that the synthesis and
activity of those substances derived from themetabolism of
arachidonic acid depend on themicroenvironment, and the
correct distribution of enzymes and receptors in different
tissues and cells [39,43,44]. Thus, differences between
study findings may be due to methodological differences,
including the types and condition of medium, as well as the
type of oocytes used. For example, in the study of Nuttinck
et al, 2011 [23] and 2017 [24], PGE2 was added to the IVM
and IVF media and serumwas used. In our study, PGs were
added only to the IVM medium, and BSA was used instead
of serum. Also, pools of oocytes from a donor of different
breeds (mainly Bos indicus breeds), raised under different
conditions were used. Therefore, the results did not sup-
port the hypothesis that inclusion of PGE2 and PGF2a in the
IVM culture will improve oocyte maturation and embryo
production. Therefore, the role of PGE2 and PGF2a during
the IVM of bovine oocytes remains unclear.
Considering that the expression of PTGS2 in vivo, which
is essential for PGs synthesis, depends on follicle size [10],
we wanted to determine if the effect of PGs varied ac-
cording to the level of competence of the oocytes. There-
fore, we evaluated the expression profiles of genes
encoding the enzymes involved in PGs synthesis and ac-
tivity in CCs and oocytes with different degrees of compe-
tence. Follicle size was used to obtain COCs with different
competencies; this model is well established in our labo-
ratory [27–29]. Therefore, large follicles were used to
obtain competent COCs, and smaller follicles were used to
obtain less-competent COCs. The results showed that the
relative abundance of the PTGS2 gene increased after 24 h
of IVM in the incompetent group, and remained unchanged
in the other group. Previous studies have reported a vari-
able expression pattern for this gene because PTGS2
expression levels increased [18,22,36,42,45,46] or were not
altered at the end of maturation [17,22].
Prostaglandin endoperoxide synthase 2 is an enzyme
responsible for the conversion of arachidonic acid to PGH2,
a common precursor of all PGs. In vivo, the gonadotrophic
peak induces PTGS2 expression in granulosa cells of the
preovulatory follicle [10–12,35]. However, expression
under physiological conditions is dependent on the follicle
size and the moment of induction because it only occurs in
follicles that reach a minimum diameter of 8 mm in cattle
[10]. By contrast, in vitro COCs aspirated from 3 to 6 mm
follicles express PTGS2 shortly after aspiration and during
IVM [42]. The levels of PTGS2 during IVM have been shown
to increase at 6 h, reaching maximum concentrations and
then decreasing at 12 [17], 18, or 24 h [22]. In the present
study, the expression of PTGS2 increased after 24 h of
culture in the incompetent group only. Therefore, it is
possible that the induction of PTGS2 in the CCs of this group
was delayed, whereas in the competent groups, the highest
expression may have occurred during the first hours of
maturation before subsequently decreasing, asdemonstrated in the literature [17,22]. These results,
therefore, confirm that the level of PTGS2 induction may be
related to follicular size [10,17,18,36,42,47,48].
In addition to PTGS2, the relative abundance of PTGES1
also increased during IVM in this study. The increased
expression occurred in the CCs of incompetent oocytes and
also in the competent group, suggesting a possible role of
this enzyme during maturation. PTGS2 and PTGES1 are
inducible enzymes associated with the intracellular mem-
brane and are responsible for the synthesis of PGE2 in
several tissues [16,36,49]. In COCs, Nuttinck et al [18] re-
ported that the induction of PTGES1 expression occurs in
parallel with the induction of PTGS2. The study by Marei
et al [17] showed that expression of both of these genes was
induced during IVM, and that after 24 h, there was an in-
crease only in the relative abundance of the PTGES1 gene.
Therefore, the induction of PTGS2 and PTGES1 activity ap-
pears to occur sequentially throughout IVM. An increase in
PTGS2 observed in the competent groupmay have occurred
early during IVM,which could have triggered the increase in
PTGES1 observed at 24 h of maturation. In the incompetent
group, the induction of PTGS2 may have occurred later;
therefore, at 24 h of IVM, PTGS2 expression remained high,
which would have induced PTGES1 transcription.
Although PTGS2 expression in CCs has also been asso-
ciated with increased PGF2a concentration in the follicular
fluid and maturation media [11,12,17,18,35,36,38,41], few
studies have investigated the specific synthase enzyme
responsible for the conversion of PGH2 to PGF2a in the
COC. As the PTGFS involved in PGF2a synthesis in the fol-
licle remains unknown, we selected the AKR1B1 gene
because it is considered to be the main enzyme responsible
for PGF2a synthesis in the bovine and human End [19,50].
Our results showed that AKR1B1 expression decreased in
the CCs of the incompetent group after 24 h of maturation,
whereas expression remained unchanged in the other
group. Considering that this is the first report of AKR1B1 in
bovine COCs of different competencies, its characterization
is important. According to Pépin et al [19], the enzyme
AKR1B1 is constitutively expressed at moderate levels in
the bovine End, and the production of PGF2a in this tissue
results from the induced expression of PTGS2. Based on
those reports and the result of the present study, we can
hypothesize that the AKR1B1 gene is also constitutively
expressed in the CCs. Thus, in the competent group, the
levels of AKR1B1 remained unchanged during maturation.
In the incompetent group, there may have been a decrease
in mRNA levels because of its translation and subsequent
degradation. Therefore, it is possible that those CCs had to
use that RNA and were unable to respond to the stimulus to
replenish the mRNA stock.
When the expression of each gene at a given time (0 or
24 h) was compared between groups, PTGS2 was the only
differentially expressed gene and was expressed at lower
levels in the competent group at 24 h than in the incom-
petent groups. Although we did not compare the expres-
sion of PTGS2 and PTGES1 at different time points of
maturation, our results led us to suppose that the greatest
expression of PTGS2 in the competent group may have
occurred in the first hours of maturation, which could be
triggering PTGES1 activity. Although abundance of mRNA
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profile during maturation according to the competence of
the COCs, the expression was similar between those COCs
when they were analyzed at a specific time point during
maturation. These results are consistent with the literature
regarding the possible use of PTGS2 as a marker of
competence [36,47,48,51].
Prostaglandin E2 acts through 4 receptors, PTGER1–
PTGER4, and PGF2a functions through the PTGFR; the char-
acteristics, physiological effects, andmechanisms of action of
each subtype differ [52]. Bovine CCs express all PTGER iso-
forms, except for PTGER1,whereas only PTGER2 is expressed
on the oocyte [23,42]. Conversely, no study has quantified
the expression of PTGFR in this cell. In the present study, we
evaluated the expression of specific PGE2 (PTGER2) and
PGF2a (PTGFR) receptors in oocytes of different compe-
tencies. Our results showed that PGE2 was expressed at low
levels, and that PGF2a receptor expressionwas undetectable
in oocytes, regardless of the competence level. ThemRNA for
both receptors was detected in CCs, CL, End, and bovine Plac,
but not in oocytes. Although PTGER2 expression has been
reported in oocytes [23,42], Calder et al [42] showed that the
composition of the maturation medium has a marked effect
on the relative abundance of PTGER2 mRNA. In addition,
numerous reports have shown that the transcriptional
levels, as well as the rates of development and embryonic
morphology, are affected by protein supplementation
[30,53]. Thus, in the present study, the use of BSA may have
influenced the expression of the receptors, unlike other
studies that used serum or another protein source.
The results of our study indicate that during IVM, PGE2
and PGF2a have no positive effect on bovine embryo
development; therefore, supplementation with these
agents during IVM/IVF is not recommended. This study also
reported the expression of AKR1B1 in bovine COCs of
different competencies for the first time. Although genes
involved in the activity of these PGs are differentially
expressed in CCs of COCs of different competence during
maturation, low or no expression of PGs receptor mRNA
was detected in oocytes.
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